[1]
Sinaga, A.H., Zebua, M., Berlian, G. and Aripin, A. 2026. Pharmacoeconomic Evaluation and Clinical Outcomes of Channa as an Adjuvant to 20% Human Albumin Therapy in Patients with Chronic Kidney Disease: A Cost-Effectiveness Analysis (CEA) at Imelda Pekerja Indonesia General Hospital. Jurnal Teknik Indonesia. 5, 01 (Aug. 2026), 178–187.